8-KFiled Jul 23, 8:00 PM ET

Surgery Partners Announces Sale of Idaho Falls Hospitals to Intermountain Health

$SGRY · Surgery Partners, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Surgery Partners Announces Sale of Idaho Falls Hospitals to Intermountain Health

What Happened Surgery Partners, Inc. (SGRY) announced that a subsidiary entered into agreements to sell its ownership interests in Mountain View Hospital, LLC (MVH) and Idaho Falls Community Hospital, LLC (IFCH) to Intermountain Health. On July 21, 2026 the parties’ signature pages were placed into escrow; the company issued a press release on July 24, 2026. Release of signatures from escrow and closing remain subject to MVH physician and governing board approvals, seller certifications, and other customary closing conditions and regulatory clearances.

Key Details

  • Combined valuation of the facilities is approximately $1.15 billion; Surgery Partners’ total consideration is approximately $795 million.
  • Final cash proceeds are subject to customary purchase price adjustments (indebtedness, working capital, transaction expenses), so the company cannot yet estimate net cash proceeds.
  • Transaction covers Surgery Partners’ hospital operations for Mountain View Hospital and Idaho Falls Community Hospital and their subsidiaries; physician ownership of Mountain View Hospital will remain unchanged.
  • Closing depends on release of signatures from escrow, Hart‑Scott‑Rodino waiting periods, other regulatory approvals, and material third‑party consents; either party may terminate if the deal does not close within 60 days after escrow release (with limited extensions).

Why It Matters This is a material divestiture of Surgery Partners’ Idaho Falls hospital operations and will change the company’s asset mix and future hospital revenues. The announced consideration provides a rough measure of value, but investors should note that final cash received will depend on post‑closing adjustments and regulatory approvals. Watch for updates on escrow release, physician and regulatory approvals, final purchase price adjustments, and disclosures on how proceeds will be used or affect the company’s financials.